Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Aerosol: SOP for Generating Validation Protocols for Aerosols – V 2.0

Posted on By

Aerosol: SOP for Generating Validation Protocols for Aerosols – V 2.0

SOP for Generating Validation Protocols for Aerosols

Department Aerosol
SOP No. SOP/Aerosol/114/2025
Supersedes SOP/Aerosol/114/2022
Page No. Page 1 of Y
Issue Date 06/02/2025
Effective Date 16/02/2025
Review Date 06/02/2028

1. Purpose

This Standard Operating Procedure (SOP) outlines the process for generating validation protocols for aerosol products. The objective of this SOP is to establish a structured approach for creating validation protocols that ensure aerosol manufacturing processes are validated in compliance with Good Manufacturing Practice (GMP) and regulatory requirements. Proper validation ensures that the processes used to manufacture aerosol products are reproducible and consistent, and consistently produce products that meet quality standards.

2. Scope

This SOP applies to all aerosol products at [Company Name] that require process validation. It includes the generation of validation protocols for both new products and existing products undergoing re-validation due to process changes or equipment upgrades. This procedure also applies to various stages of the manufacturing process including formulation, filling, crimping, and packaging.

3. Responsibilities

  • Validation Team: Responsible for drafting the validation protocol, defining the scope, and identifying critical process parameters (CPPs). They are also responsible for ensuring that the protocol complies with GMP and regulatory standards.
  • Production Team: Responsible for providing process-related data, assisting in identifying critical parameters, and executing the validation runs according to the
protocol.
  • Quality Assurance (QA) Team: Responsible for reviewing and approving the validation protocol and ensuring that the process validation activities comply with GMP, regulatory guidelines, and internal quality standards.
  • Regulatory Affairs Team: Ensures the validation protocol aligns with applicable regulatory requirements and monitors compliance with regulatory guidelines throughout the validation process.
  • 4. Accountability

    The Manufacturing Manager is accountable for ensuring that the validation protocols are generated and executed in accordance with this SOP. The overall compliance with this SOP is overseen by the Quality Assurance (QA) Manager.

    5. Procedure

    5.1. Developing the Validation Protocol

    1. The validation protocol should be developed for each aerosol product and the associated manufacturing process. The protocol must include the following elements:
      • Title and Objective: Clear title and objective outlining the validation process (e.g., Process Validation, Equipment Qualification, Cleaning Validation).
      • Scope: Description of the scope of the validation, including the equipment, processes, and parameters to be validated.
      • Test Parameters: Definition of the critical process parameters (CPPs) that affect the quality of the final product. These parameters should include both in-process and end-product quality attributes (e.g., spray rate, filling accuracy, propellant concentration).
      • Acceptance Criteria: Clear criteria outlining what constitutes a successful validation run, including limits for all test parameters (e.g., ±5% for filling accuracy, pH range for formulation).
      • Sampling Plan: A sampling plan detailing the frequency of testing, number of samples to be tested, and any additional tests required at different stages of the process.
      • Methodology: Step-by-step instructions for executing the validation, including specific actions for each stage of the process.
      • Roles and Responsibilities: Clear definition of roles and responsibilities of each team involved in the validation process (e.g., validation team, production team, QA team).
    2. The protocol should be reviewed and approved by the QA team to ensure it aligns with GMP standards, regulatory requirements, and the specific needs of the product.

    5.2. Protocol Review and Approval

    1. The draft protocol must be reviewed by relevant departments, including QA, production, regulatory affairs, and validation. Each department must ensure that the protocol meets their requirements and that all critical aspects of the process are covered.
    2. Once the protocol is reviewed and final adjustments are made, it should be signed and approved by the QA Manager and Manufacturing Manager. The approved protocol should be stored and referenced throughout the validation process.

    5.3. Conducting the Validation Runs

    1. Once the validation protocol is approved, the validation runs should be conducted following the established protocol. The production team will execute the manufacturing process according to the protocol, ensuring all specified parameters are met.
    2. During validation, the following steps should be closely monitored:
      • Monitor the identified critical process parameters (e.g., pressure, temperature, filling volume).
      • Perform quality control tests on the product (e.g., appearance, chemical composition, spray rate) to ensure that it meets the acceptance criteria.
      • Record data accurately for all test parameters and deviations, if any.
    3. All records from the validation runs should be collected and compiled in the Process Validation Report (Annexure-1), which will include the results of all tests, any deviations or non-conformities, and corrective actions taken.

    5.4. Documentation and Reporting

    1. After completing the validation runs, the results must be documented in a comprehensive validation report. The Process Validation Report should include:
      • Summary of validation runs
      • Test results for each parameter
      • Analysis of deviations and corrective actions taken
      • Final conclusions on the process’s ability to meet required specifications
    2. The report must be reviewed and approved by the QA team and relevant departments to ensure that all data is accurate and the process meets all requirements.
    3. The final validated process and protocol must be documented and archived for future reference and regulatory audits.

    5.5. Revalidation

    1. Revalidation is required if significant changes are made to the process, equipment, or formulation that could impact the process or product quality. In such cases, the validation protocol should be revised and re-executed according to the same procedures outlined in this SOP.
    2. Revalidation should also be considered if process deviations occur during routine production or if quality control tests indicate that product quality may be affected.

    6. Abbreviations

    • GMP: Good Manufacturing Practice
    • QA: Quality Assurance
    • SOP: Standard Operating Procedure
    • CPP: Critical Process Parameter
    • OQ: Operational Qualification
    • PQ: Performance Qualification
    • CFR: Code of Federal Regulations

    7. Documents

    1. Process Validation Report (Annexure-1)
    2. Deviation Log (Annexure-2)

    8. References

    This SOP is based on the following regulatory guidelines and industry standards:

    • Good Manufacturing Practice (GMP) Guidelines
    • FDA Code of Federal Regulations (CFR) Title 21, Part 211
    • International Council for Harmonisation (ICH) Guidelines

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Process Validation Report

    Batch Number Validation Date Result Remarks
    Batch-001 10/02/2025 Pass All parameters within acceptable range

    Annexure-2: Deviation Log

    Deviation ID Deviation Description Corrective Action Responsible Person Status
    DEV-12345 Temperature fluctuation Recalibrated temperature control Rajesh Patel Completed

    12. Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By Page No. Ref. Point No. Details of Revision
    01/01/2024 V 1.0 Initial Release First Issue Anjali Sharma Page 1 [Ref Point] First Release
    01/01/2025 V 2.0 Updated validation protocol generation process To comply with updated GMP regulations Anjali Sharma Page 1 [Ref Point] Updated procedures
    See also  Aerosol: SOP for Selecting Packaging Materials for Stability Studies - V 2.0
    Aerosols V 2.0 Tags:Aerosol Batch Production, Aerosol Can Design, Aerosol Cold Filling, Aerosol Documentation Standards, Aerosol Emissions Control, Aerosol Environmental Regulations, Aerosol equipment calibration, Aerosol Filling Process, Aerosol Fire Safety Measures, Aerosol Formulation, Aerosol Good Manufacturing Practice (GMP), Aerosol Hazardous Materials Handling, Aerosol Incident Reporting, Aerosol Leak Testing, Aerosol Maintenance Schedules, Aerosol Personal Protective Equipment (PPE), Aerosol Pressure Filling, Aerosol Product Labeling, Aerosol Product Testing, Aerosol Propellant Selection, Aerosol quality control, Aerosol Regulatory Compliance, Aerosol Risk Assessment, Aerosol Safety Protocols, Aerosol Standard Operating Procedures (SOPs), Aerosol Storage Requirements, Aerosol Training Programs, Aerosol Valve Crimping, Aerosol Ventilation Systems, Aerosol Waste Disposal

    Post navigation

    Previous Post: Creams: SOP for Validating Mixing Speeds in Cream Manufacturing Equipment – V 2.0
    Next Post: Tablets: SOP for Strip Packing Process for Coated Tablets – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version